Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1971 2
1972 3
1973 10
1974 21
1975 31
1976 35
1977 39
1978 34
1979 46
1980 68
1981 54
1982 61
1983 70
1984 63
1985 66
1986 78
1987 65
1988 81
1989 74
1990 73
1991 75
1992 71
1993 93
1994 73
1995 76
1996 68
1997 92
1998 54
1999 72
2000 53
2001 68
2002 68
2003 76
2004 73
2005 81
2006 59
2007 60
2008 66
2009 54
2010 66
2011 75
2012 81
2013 67
2014 62
2015 71
2016 66
2017 76
2018 71
2019 79
2020 101
2021 84
2022 67
2023 80
2024 74
2025 68

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,317 results

Results by year

Filters applied: . Clear all
Page 1
Dantrolene.
Britt BA. Britt BA. Can Anaesth Soc J. 1984 Jan;31(1):61-75. doi: 10.1007/BF03011484. Can Anaesth Soc J. 1984. PMID: 6362802 Review. No abstract available.
Malignant hyperthermia.
Tomarken JL, Britt BA. Tomarken JL, et al. Ann Emerg Med. 1987 Nov;16(11):1253-65. doi: 10.1016/s0196-0644(87)80235-4. Ann Emerg Med. 1987. PMID: 3310764 Review.
Malignant hyperthermia.
Ali SZ, Taguchi A, Rosenberg H. Ali SZ, et al. Best Pract Res Clin Anaesthesiol. 2003 Dec;17(4):519-33. doi: 10.1016/j.bpa.2003.09.012. Best Pract Res Clin Anaesthesiol. 2003. PMID: 14661655 Review.
Immediate discontinuation of triggering agents, oxygenation, and correction of acidosis and electrolyte abnormalities, cooling and dantrolene are essential for treatment of the syndrome. Thanks to clinical and research investigations, widespread education and the introduct …
Immediate discontinuation of triggering agents, oxygenation, and correction of acidosis and electrolyte abnormalities, cooling and dantro …
[Sodium dantrolene].
Campos Suárez JM, Escolano Villén F, Catalá Puigbó E, Villar Landeira JM, Sanz Mazó M. Campos Suárez JM, et al. Rev Esp Anestesiol Reanim. 1985 Jul-Aug;32(4):179-83. Rev Esp Anestesiol Reanim. 1985. PMID: 3901158 Review. Spanish. No abstract available.
Spasticity.
[No authors listed] [No authors listed] Lancet. 1989 Dec 23-30;2(8678-8679):1488-90. Lancet. 1989. PMID: 2574771 Review. No abstract available.
Dantrolene, a treatment for Alzheimer disease?
Liang L, Wei H. Liang L, et al. Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):1-5. doi: 10.1097/WAD.0000000000000076. Alzheimer Dis Assoc Disord. 2015. PMID: 25551862 Free PMC article. Review.
Normalization of intracellular Ca homeostasis could be an effective strategy for AD therapies. Dantrolene, an antagonist of ryanodine receptors and an FDA-approved drug for clinical treatment of malignant hyperthermia and muscle spasms, exhibits neuroprotective effects in …
Normalization of intracellular Ca homeostasis could be an effective strategy for AD therapies. Dantrolene, an antagonist of ryanodine …
Dantrolene preparation.
Russell T, Steel A. Russell T, et al. Anaesth Intensive Care. 2011 Nov;39(6):1150; author reply 1150-1. Anaesth Intensive Care. 2011. PMID: 22165375 No abstract available.
[Peranesthetic malignant hyperthermia].
Stieglitz P. Stieglitz P. Ann Fr Anesth Reanim. 1988;7(4):275. doi: 10.1016/s0750-7658(88)80028-5. Ann Fr Anesth Reanim. 1988. PMID: 3202337 French. No abstract available.
Dantrolene and ryanodine receptors in COVID-19: The daunting task and neglected warden.
Alkazmi L, Al-Kuraishy HM, Al-Gareeb AI, El-Bouseary MM, Ahmed EA, Batiha GE. Alkazmi L, et al. Clin Exp Pharmacol Physiol. 2023 May;50(5):335-352. doi: 10.1111/1440-1681.13756. Epub 2023 Feb 28. Clin Exp Pharmacol Physiol. 2023. PMID: 36732880 Review.
Dantrolene (DTN) is a ryanodine receptor (RyR) antagonist that inhibits Ca(2+) release from stores in the sarcoplasmic reticulum. ...
Dantrolene (DTN) is a ryanodine receptor (RyR) antagonist that inhibits Ca(2+) release from stores in the sarcoplasmic reticulum. ...
Approaches to Optimizing Dantrolene Neuroprotection for the Treatment of Alzheimer's Disease.
Abou MB, Sun L, Wei H. Abou MB, et al. Curr Alzheimer Res. 2020;17(4):324-328. doi: 10.2174/1567205017666200522204722. Curr Alzheimer Res. 2020. PMID: 32442084 Free PMC article. Review.
However, the inefficiency of dantrolene to pass the Blood Brain Barrier (BBB) and penetrate the Central Nervous System needs to be resolved, considering its dose-dependent neuroprotection in AD and other neurodegenerative diseases. In this mini-review, we will discuss the …
However, the inefficiency of dantrolene to pass the Blood Brain Barrier (BBB) and penetrate the Central Nervous System needs to be re …
3,317 results